CasaPharma
ActiveSummary
CasaPharma has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€1,242) and a net result of -€683. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 10,771 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
1 director, last change in 2024
Erika Rottey
CurrentSole director · since 20-10-2023
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
3 people since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Erika Rottey |
|
| ROEGIERS Paul Maurice Maria |
|
| Paul Roegiers |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
Stated in the act
act of 25-02-2026 ↗
- Erika Rottey all shares
Share transfer
act of 25-02-2026 ↗
- parties not read
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 05-01-2024 Converted to unavailable equity